New Products and Industry News

Computerized wound analysis system receives clearance

  Aranz Medical Limited (Christchurch, New Zealand) announces that the Silhouette™, a computerized wound imaging, analysis, and documentation system, recently received 510(k) pre-market clearance from the US Food and Drug Administration (FDA).

  The system uses a custom-designed camera, which accurately relays quantitative information to an electronic patient record for printing, electronic distribution, and archiving.

  For more information, visit www.aranzmedical.com.

Spray-on products offer comfortable healing

  Cawthon’s Touchless Care Concepts (Louisville, KY) formulates and distributes spray-on ointments designed to treat diaper rash and various skin problems. The spray’s inventor is Garret Cawthon, who is responsible for several other patented inventions. Usage of the spray does not involve direct contact with the skin, avoiding further irritation and epidermal damage.  

 The diaper-rash medication market with annual sales of $500 million for older patients is substantially greater than the infant market and this product is useful among patients of all ages.

  For more information, visit www.ithacajournal.com/apps/pbcs.dll/article?AID=/20070914/LIFESTYLE06/709140317.

Collaboration results in development of wound care product

  Innocoll Technologies Ltd. (Ashburn, VA), has entered into a strategic collaboration with TGR BioSciences Pty Ltd. (Adelaide, South Australia) to evaluate the combination of Innocoll’s collagen-based drug delivery technology, CollaRx® with TGR Biosciences’ proprietary wound healing compound, TGR-265. Innocoll’s CollaRX technology platform is a biocompatible and fully bioresorbable collagen matrix for localized drug delivery.

  Comprised of purified type I fibrillar collagen, it can be prepared in the form of a lyophilized sponge or film-cast membrane using a proprietary manufacturing process. Both CollaRX formats can be surgically implanted or applied topically to wounds, enabling drugs to be delivered locally to the intended site of action–minimizing any systemic-related side effects.

   TGR-265 is a naturally derived bioactive protein that has been show through extensive in vitro and in vivo pre-clinical testing to stimulate the fibrogenic response during the production of host type I collagen and deposition of intracellular matrix.  

 For more information, visit www.innocoll.com or www.tgr-biosciences.com.au.

Innovative skin patches heal wounds

  BIOFISICA (Duluth, GA) premiered a new smart skin patch that heals wounds by restoring the natural electrical signals in the skin at the site of a wound.

  The smart patch has a button battery driving an integrated circuit that delivers a specific customized voltage pattern to the wound area using a hydrogel that is biocompatible. The patch utilizes two contacts, an anode and cathode–both are used to maintain and deliver the bio-current to the wound.

  The POSiFECT® monitor attached to the patch’s dressing contains a tightly controlled microcurrent delivery system. This system continuously adjusts the microcurrent levels, which are clinically shown to initiate the wound healing process.

  For more information, visit www.biofisica.com.

New wound gel offers antimicrobial protection

  Swiss-American Products, Inc. (Dallas, TX) released Elta® SilverGel™, an advanced ionic-silver wound gel that offers antimicrobial protection for a wide range of wounds, pressure ulcers, skin grafts, and donor sites.

  The gel allows healthcare providers to see through the gel to the wound bed by forming a coat within the wound bed and it can be applied directly to wounds.

  For more information, visit https://www.elta.net.